Prime Securities Launches ₹1,000 Crore Fund to Target High-Yield Real Estate Debt

Source: Economictimes
Arth Insight · What this means for your wallet
- This fund offers structured credit to real estate developers, not direct property ownership for you.
- It aims for high returns (18-20% IRR) but comes with high risks, suitable only for very wealthy investors.
- For the average Indian, this news signals that big money is flowing into real estate, potentially stabilizing or increasing property values in major cities.
Prime Litmus Investment Management has introduced a new Category II Alternative Investment Fund aimed at under-construction residential projects. The fund seeks to raise up to ₹1,000 crore by offering structured credit to developers in India’s top metropolitan cities.
- ▸The fund acts as a lender to developers of under-construction projects in major Indian cities.
- ▸It aims for high returns of 18-20% over a six-year period through structured debt.
- ▸The total fund size could reach ₹1,000 crore including the green shoe option.
- ▸It offers a regulated avenue for wealthy investors to gain exposure to real estate credit.
- ✓The fund acts as a lender to developers of under-construction projects in major Indian cities.
- ✓It aims for high returns of 18-20% over a six-year period through structured debt.
- ✓The total fund size could reach ₹1,000 crore including the green shoe option.
- ✓It offers a regulated avenue for wealthy investors to gain exposure to real estate credit.
Prime Securities, through its investment arm Prime Litmus Investment Management, has announced the launch of the 'Prime Litmus Real Estate Opportunities Fund.' This new Category II Alternative Investment Fund (AIF) is designed to tap into the credit requirements of India’s rebounding real estate sector, offering high-net-worth individuals a structured way to participate in property debt.
Fund Size and Growth Strategy
The fund has set a base target of ₹750 crore, with an additional 'green shoe' option of ₹250 crore, bringing the total potential corpus to ₹1,000 crore. Unlike traditional equity funds that buy into property ownership, this fund focuses on structured credit. This means it lends money to developers, securing the investment against the project's cash flows and assets.
The management team is targeting an Internal Rate of Return (IRR) in the range of 18% to 20%. The fund has a designated tenure of six years, aligning with the typical lifecycle of mid-to-large scale residential developments.
Focus on Metropolitan Markets
The Prime Litmus Real Estate Opportunities Fund will concentrate its capital on under-construction projects located in India’s primary metropolitan regions. These areas often face a 'credit gap' where developers require flexible funding that traditional banks may not provide due to regulatory constraints on land or early-stage construction financing.
Investment Structure and Benefits
By operating as a Category II AIF, the fund provides a regulated vehicle for sophisticated investors to earn higher yields than those typically found in standard fixed-income products. The core strategy involves:
- Structured Credit: Providing customized loans to developers with clear exit timelines.
- Under-Construction Projects: Focusing on the high-growth phase of real estate where capital demand is peak.
- Risk Management: Diversifying across multiple projects in key growth corridors to mitigate localized market risks.
The launch comes at a time when the Indian real estate market is seeing a resurgence in demand for residential units, particularly in the premium and mid-income segments. By bridging the funding gap for developers, Prime Litmus aims to capture high interest margins while ensuring the underlying projects have the necessary liquidity to reach completion.
Investment in Alternative Investment Funds involves high risk; please consult with a financial advisor and read all fund-related documents carefully before investing.
Loan interest rates, processing fees and eligibility are set by the lender and subject to credit approval — verify current terms before applying. Some listings may be sponsored. Not financial advice.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about real-estate

ChrysCapital and Tata Capital Inject ₹584 Crore into Linux Laboratories
Linux Laboratories has secured approximately ₹584 crore ($70 million) in equity funding from investment giants ChrysCapital and Tata Capital Healthcare Fund III. This significant investment will enable Linux Laboratories to expand its presence in existing and new therapeutic areas within the healthcare sector.
BreakingSupreme Court Flags High Cancer Drug Prices, Urges Government Price Cap
The Supreme Court has expressed serious concern over the exorbitant pricing of essential medicines, particularly cancer drugs, sold with huge markups. Justices Vikram Nath and SVN Bhatti urged the government to consider a uniform pricing rule to cap Maximum Retail Prices (MRPs), highlighting the burden on ordinary people and taxpayers.
BreakingNiti Aayog Plans National Quality Grades for Hospitals to Boost Patient Choice
Niti Aayog is developing a national quality framework to grade both public and private hospitals in India. This initiative aims to help patients compare healthcare providers more easily and improve overall quality standards. The framework will assess factors like patient safety, clinical outcomes, and readmission rates.
Related Stories

ChrysCapital and Tata Capital Inject ₹584 Crore into Linux Laboratories
Linux Laboratories has secured approximately ₹584 crore ($70 million) in equity funding from investment giants ChrysCapital and Tata Capital Healthcare Fund III. This significant investment will enable Linux Laboratories to expand its presence in existing and new therapeutic areas within the healthcare sector.
BreakingSupreme Court Flags High Cancer Drug Prices, Urges Government Price Cap
The Supreme Court has expressed serious concern over the exorbitant pricing of essential medicines, particularly cancer drugs, sold with huge markups. Justices Vikram Nath and SVN Bhatti urged the government to consider a uniform pricing rule to cap Maximum Retail Prices (MRPs), highlighting the burden on ordinary people and taxpayers.
BreakingNiti Aayog Plans National Quality Grades for Hospitals to Boost Patient Choice
Niti Aayog is developing a national quality framework to grade both public and private hospitals in India. This initiative aims to help patients compare healthcare providers more easily and improve overall quality standards. The framework will assess factors like patient safety, clinical outcomes, and readmission rates.

CDSCO, Home Ministry Boost Efforts to Stop Illegal Pharma Drug Diversion
India's Central Drugs Standard Control Organisation (CDSCO) is stepping up measures to prevent the illegal diversion of pharmaceutical drugs, particularly those containing narcotic substances. This significant move follows a directive from the National Committee for Coordination on Drug Trafficking, with Union Home Minister Amit Shah emphasizing a united strategy to combat evolving drug trafficking challenges. The Drugs Consultative Committee will review existing regulations to recommend critical improvements.